How big is the UAE In-Vitro Diagnostics Market?

The UAE In-Vitro Diagnostics Market size is expected to reach USD 423.56 million in 2024 and grow at a CAGR of 5.20% to reach USD 547.86 million by 2029. Read More

What is the current UAE In-Vitro Diagnostics Market size?

In 2024, the UAE In-Vitro Diagnostics Market size is expected to reach USD 423.56 million. Read More

Who are the key players in UAE In-Vitro Diagnostics Market?

bioMérieux, Abbott Laboratories, F Hoffmann-La Roche Ltd, Siemens Healthineers AG and QIAGEN are the major companies operating in the UAE In-Vitro Diagnostics Market. Read More

What years does this UAE In-Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the UAE In-Vitro Diagnostics Market size was estimated at USD 401.53 million. The report covers the UAE In-Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the UAE In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

UAE In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 UAE In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. UAE In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of UAE In-Vitro Diagnostics Industry

The UAE In-Vitro Diagnostics market is moderately competitive due to the presence of some global players in the country along with some local market players. The major market players in the UAE In-Vitro Diagnostics market are biomérieux, QIAGEN, Abbott Laboratories, Hoffmann-La Roche Ltd, and Siemens Healthineers AG, among others.